IL2RA and myeloid sarcoma: Thirty-five years after the first report on the role of the HLA region in MS, association studies identified the first genetic risk factors for MS outside of the HLA region: variants in the cytokine receptor genes interleukin-2 receptor alpha (IL2RA) and interleukin-7 receptor (IL7R) [27-29].